Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons

被引:20
作者
Ito, Taisuke [1 ]
Kamei, Kazumasa [2 ]
Yuasa, Akira [3 ]
Matsumoto, Fumihiro [2 ]
Hoshi, Yayoi [4 ]
Okada, Masafumi [4 ]
Noto, Shinichi [5 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan
[2] Pfizer Japan Inc, Inflammat & Immunol Med Affairs, Tokyo, Japan
[3] Pfizer Japan Inc, Hlth & Value, Tokyo, Japan
[4] IQVIA Solut Japan KK, Real World Evidence Solut & HEOR, Tokyo, Japan
[5] Niigata Univ Hlth & Welf, Dept Rehabil, Niigata, Japan
关键词
alopecia areata; cross-sectional studies; mental health; patient reported outcome measures; quality of life; ATOPIC-DERMATITIS; DEPRESSION; DISEASE; SF-36; ASSOCIATION; VALIDATION; MANAGEMENT; ANXIETY; BURDEN; IMPACT;
D O I
10.1111/1346-8138.16364
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Alopecia areata (AA) is a non-scarring hair loss disorder affecting approximately 2% of the global population. AA is reported to have a significant negative impact on the emotional and psychological well-being of the patients. This study aimed to evaluate the health-related quality of life (HRQoL) of Japanese patients with AA in comparison to the Japanese population norms (national standard values for Japanese) using Short Form Health Survey 36 Item Version 2.0 (SF-36v2). The study also aimed to access the negative effect of AA on patients' daily lives and the proportion of patients having anxiety and/or depression. This cross-sectional, non-interventional web-based survey study included 400 participants aged 17-84 years currently suffering from medically diagnosed AA. The assessment tools integrated in the online questionnaire included SF-36v2, the Dermatology Life Quality Index (DLQI), and the Hospital Anxiety and Depression Scale (HADS). All outcome measures from the tools were evaluated across the study population. SF-36v2 subscale scores for patients with AA revealed lower scores specifically for mental health (45.7 +/- 10.1 points), social functioning (45.8 +/- 10.9 points), vitality (46.2 +/- 9.8 points), and role emotional (46.9 +/- 11.6 points) as compared to the Japanese population norms of 50 +/- 10 points each. The DLQI questionnaire-based analysis indicated that 32.1% of respondents showed a moderate to extremely large effect on their lives; and HADS-A (anxiety) and HADS-D (depression) scores categorized 46.0% and 41.8% respondents as doubtful-to-definite cases, respectively. Multivariate linear regression revealed that hair loss range, age, comorbidities, and depression significantly worsened DLQI scores. In conclusion, the results of this survey demonstrated that a significant decrease in the HRQoL scores was observed in Japanese patients with AA in comparison with the national norms. Hence, emphasis on mental health is crucial for AA management.
引用
收藏
页码:584 / 593
页数:10
相关论文
共 40 条
[1]   Clinical profile and impact on quality of life: Seven years experience with patients of alopecia areata [J].
Al-Mutairi, Nawaf ;
Eldin, Osama Nour .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2011, 77 (04) :90-94
[2]   Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey [J].
Arima, Kazuhiko ;
Gupta, Shaloo ;
Gadkari, Abhijit ;
Hiragun, Takaaki ;
Kono, Takeshi ;
Katayama, Ichiro ;
Demiya, Sven ;
Eckert, Laurent .
JOURNAL OF DERMATOLOGY, 2018, 45 (04) :390-396
[3]  
Askin Ozge, 2022, Int J Adolesc Med Health, V34, P315, DOI 10.1515/ijamh-2020-0100
[4]   The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results [J].
Basra, M. K. A. ;
Fenech, R. ;
Gatt, R. M. ;
Salek, M. S. ;
Finlay, A. Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) :997-1035
[5]   Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata [J].
Bilgic, O. ;
Bilgic, A. ;
Bahali, K. ;
Bahali, A. G. ;
Gurkan, A. ;
Yilmaz, S. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (11) :1463-1468
[6]   The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study [J].
Bitan, Dana Tzur ;
Berzin, Daniella ;
Kridin, Khalaf ;
Cohen, Arnon .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (05) :463-468
[7]   Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes [J].
Chernyshov, P. V. ;
Tomas-Aragones, L. ;
Finlay, A. Y. ;
Manolache, L. ;
Marron, S. E. ;
Sampogna, F. ;
Spillekom-van Koulil, S. ;
Pustisek, N. ;
Suru, A. ;
Evers, A. W. M. ;
Salavastru, C. ;
Svensson, A. ;
Abeni, D. ;
Blome, C. ;
Poot, F. ;
Jemec, G. B. E. ;
Linder, D. ;
Augustin, M. ;
Bewley, A. ;
Salek, S. S. ;
Szepietowski, J. C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) :1614-1621
[8]   Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: A nationwide population-based study [J].
Dai, Ying-Xiu ;
Tai, Ying-Hsuan ;
Chen, Chih-Chiang ;
Chang, Yun-Ting ;
Chen, Tzeng-Ji ;
Chen, Mu-Hong .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) :1131-1137
[9]   Development of a disease-specific instrument to measure quality of life in patients with alopecia areata [J].
Endo, Yuichiro ;
Miyachi, Yoshiki ;
Arakawa, Akiko .
EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (04) :531-536
[10]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216